Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.

The US Food and Drug Administration (FDA) Expanded Access (EA) Program, which allows for compassionate uses of unapproved therapeutics and diagnostics outside of clinical trials, has gained significant traction during the Coronavirus 2019 (COVID-19) pandemic. While development of vaccines has been t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Drug Discov Today
Huvudupphovsmän: Rizk, John G., Forthal, Donald N., Kalantar-Zadeh, Kamyar, Mehra, Mandeep R., Lavie, Carl J., Rizk, Youssef, Pfeiffer, JoAnn P., Lewin, John C.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier Ltd. 2021
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7694556/
https://ncbi.nlm.nih.gov/pubmed/33253920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2020.11.025
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk